| Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer T He, G Wildey, K McColl, A Savadelis, K Spainhower, C McColl, ... Molecular Oncology 15 (1), 195-209, 2021 | 15 | 2021 |
| Post‐transcriptional regulation of PIAS 3 expression by miR‐18a in malignant mesothelioma T He, K McColl, N Sakre, Y Chen, G Wildey, A Dowlati Molecular oncology 12 (12), 2124-2135, 2018 | 15 | 2018 |
| PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity G Varuzhanyan, CC Chen, J Freeland, T He, W Tran, K Song, L Wang, ... Proceedings of the National Academy of Sciences 121 (49), e2416882121, 2024 | 1 | 2024 |
| Defining the role of RUNX1T1 in "combined" small cell lung cancer. T He, G Wildey, K McColl, A Kresak, AC Tan, A Dowlati Journal of Clinical Oncology 37 (15_suppl), e20101-e20101, 2019 | 1 | 2019 |
| Identification and clinical significance of two divergent regulators in thoracic malignancy: miR-18a and RUNX1T1 T He Case Western Reserve University, 2021 | | 2021 |
| RUNX1T1 is amplified in combined small cell lung cancer T He, K McColl, A Savadelis, Y Chen, G Wildey, A Dowlati Cancer Research 78 (13_Supplement), 2495-2495, 2018 | | 2018 |
| Post-transcriptional regulation on PIAS3 expression in malignant mesothelioma T He, K McColl, N Sakre, G Wildey, A Dowlati Cancer Research 77 (13_Supplement), 4490-4490, 2017 | | 2017 |
